Lisa Humphrey

Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.

Jing Wang, J. Willson, J. Hauser, 2006, Cancer research.